Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism IGF2BP1 modulators(insulin like growth factor 2 mRNA binding protein 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC42H52FN3O10 |
InChIKeyTYPLITLLZBGXGF-WDARCNGKSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Discovery | CN | 08 Sep 2023 |